More frequent lab tests will be recommended for rheumatoid arthritis patients taking Arava (leflunomide)

January 2004

More frequent lab tests will be recommended for rheumatoid arthritis patients taking Arava (leflunomide).

This is due to potential hepatotoxicity or severe infections due to immunosuppression.

The biggest concern is for patients with other risk factors for hepatotoxicity or immunosuppression.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

alternatives to prevent or treat flu
Cardiology Spironolactone will be used more for hypertension
Diabetes More people will be labeled as having "pre-diabetes"
A simple new technique might help patients who get nosebleeds from nasal steroids
single-ingredient, extended-release guaifenesin products
Men's Health some medications can worsen urinary symptoms
Hematology & Oncology potential interaction between tamoxifen and paroxetine (Paxil)
Hematology & Oncology Plenaxis (abarelix), a new drug for advanced prostate cancer
Bipolar Disorder Risperdal (risperidone) is now approved for acute mania
Obesity & Weight Loss what works for weight loss
Women's Health More women will use emergency contraceptives
Women's Health Climara Pro, a new COMBINATION estrogen and progestin patch for relieving menopausal symptoms
More frequent lab tests will be recommended for rheumatoid arthritis patients taking Arava (leflunomide)
FLUIDjoint, a new supplement for osteoarthritis
Medicare The big changes to Medicare will affect your practice